{"url":"https://lda.senate.gov/api/v1/filings/4dec6027-6f19-4e4a-b2c1-fb58dfa8e56e/","filing_uuid":"4dec6027-6f19-4e4a-b2c1-fb58dfa8e56e","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/4dec6027-6f19-4e4a-b2c1-fb58dfa8e56e/print/","filing_document_content_type":"text/html","income":"45000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Sara Love Rawlings","dt_posted":"2025-04-21T18:30:08-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2618 30th Street NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20008","registrant":{"id":401104458,"url":"https://lda.senate.gov/api/v1/registrants/401104458/","house_registrant_id":43653,"name":"SL STRATEGIES, LLC","description":"health care consulting firm","address_1":"2618 30th Street NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20008","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SARA LOVE RAWLINGS","contact_telephone":"+1 662-801-6660","dt_updated":"2026-03-09T12:11:07.092404-04:00"},"client":{"id":211924,"url":"https://lda.senate.gov/api/v1/clients/211924/","client_id":125,"name":"PARTNER THERAPEUTICS","general_description":"biotechnology company","client_government_entity":false,"client_self_select":null,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to rad/nuc preparedness and response","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66631,"prefix":null,"prefix_display":null,"first_name":"SARA LOVE","nickname":null,"middle_name":null,"last_name":"RAWLINGS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66876,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"TENENBAUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147973,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"MOODY","last_name":"JOHNSON","suffix":null,"suffix_display":null},"covered_position":"U.S. Senate Committee on Health, Education, Labor and Pensions","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Fiscal Year 2025 HHS appropriations for rad/nuc preparedness and response","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66631,"prefix":null,"prefix_display":null,"first_name":"SARA LOVE","nickname":null,"middle_name":null,"last_name":"RAWLINGS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66876,"prefix":null,"prefix_display":null,"first_name":"JORDAN","nickname":null,"middle_name":null,"last_name":"TENENBAUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}